Dylane Wineland, MS, LCGC

Dylane Wineland, MS, LCGC
​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Treatment Philosophy

As a cancer genetic counselor, I strive to empower individuals and their families with the knowledge and support needed to make informed decisions about genetic testing and managing their cancer risk. I recognize the emotional impact of a cancer diagnosis and hope to educate and guide with empathy and a personalized approach to hereditary cancer risk assessment. Working at Fox Chase offers a unique opportunity to work collaboratively with the rest of the healthcare team to ensure comprehensive and integrative care. I encourage active participation in decision-making to empower individuals to take control of their healthcare journey and hope to offer resources and support during the process. 

Educational Background

  • Master of Science in Genetic Counseling, Arcadia University, August 2018 –May 2020
  • Bachelor of Science in Biology, Genetics, and Biotechnology track Minor in Psychology University of Iowa, August 2012 – May 2016

Certifications

  • Certified Genetic Counselor, American Board of Genetic Counseling (ABGC)
  • Licensed Genetic Counseling in Pennsylvania and New Jersey
     

Memberships

  • National Society of Genetic Counselors (NSGC)
  • Collaborative Group of the Americas Inherited Gastrointestinal Cancer (CGA-IGC

Selected Publications

Wineland, D., Le, A. N., Hausler, R., Kelly, G., Barrett, E., Desai, H., Wubbenhorst, B., Pluta, J., Bastian, P., Symecko, H., D'Andrea, K., Doucette, A., Gabriel, P., Reiss, K. A., Nayak, A., Feldman, M., Domchek, S. M., Nathanson, K. L., Maxwell, K. N., Regeneron Genetics Center, … Penn Medicine Biobank (2023). Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers. JCO precision oncology, 7, e2300036. https://doi.org/10.1200/PO.23.00036

Talbot DE, Vormezeele BJ, Kimble GC, et al. Prostaglandins limit nuclear actin to control nucleolar function during oogenesis. Front Cell Dev Biol. 2023;11:1072456. Published 2023 Feb 17. doi:10.3389/fcell.2023.1072456

Wineland, D. M., Kelpsch, D. J. and Tootle, T. L. (2018), Multiple Pools of Nuclear Actin. The Anatomical Record., 301: 2014-2036. doi:10.1002/ar.23964

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​
Resize Text